KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

AbCellera Biologics (ABCL) Tax Provisions (2021 - 2023)

Historic Tax Provisions for AbCellera Biologics (ABCL) over the last 3 years, with Q4 2023 value amounting to -$1.5 million.

  • AbCellera Biologics' Tax Provisions rose 441.08% to -$1.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$27.6 million, marking a year-over-year decrease of 13429.18%. This contributed to the annual value of -$37.5 million for FY2024, which is 3585.47% down from last year.
  • AbCellera Biologics' Tax Provisions amounted to -$1.5 million in Q4 2023, which was up 441.08% from -$10.7 million recorded in Q3 2023.
  • Over the past 5 years, AbCellera Biologics' Tax Provisions peaked at $62.2 million during Q1 2022, and registered a low of -$10.7 million during Q3 2023.
  • In the last 3 years, AbCellera Biologics' Tax Provisions had a median value of -$776500.0 in 2022 and averaged $9.9 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 65576.28% in 2022, then tumbled by 730198.02% in 2023.
  • AbCellera Biologics' Tax Provisions (Quarter) stood at $24.8 million in 2021, then tumbled by 106.13% to -$1.5 million in 2022, then grew by 4.41% to -$1.5 million in 2023.
  • Its last three reported values are -$1.5 million in Q4 2023, -$10.7 million for Q3 2023, and -$7.5 million during Q2 2023.